Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation.

Bentz GL, Shackelford J, Pagano JS.

J Virol. 2012 Nov;86(22):12251-61. doi: 10.1128/JVI.01407-12. Epub 2012 Sep 5.

2.

LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.

Bentz GL, Moss CR 2nd, Whitehurst CB, Moody CA, Pagano JS.

J Virol. 2015 Aug;89(15):7465-77. doi: 10.1128/JVI.00711-15. Epub 2015 May 6.

3.

Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9.

Bentz GL, Whitehurst CB, Pagano JS.

J Virol. 2011 Oct;85(19):10144-53. doi: 10.1128/JVI.05035-11. Epub 2011 Jul 27.

4.

The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.

Ning S, Pagano JS.

J Virol. 2010 Jun;84(12):6130-8. doi: 10.1128/JVI.00364-10. Epub 2010 Apr 14.

5.
7.

TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1.

Ning S, Campos AD, Darnay BG, Bentz GL, Pagano JS.

Mol Cell Biol. 2008 Oct;28(20):6536-46. doi: 10.1128/MCB.00785-08. Epub 2008 Aug 18.

8.

The Linear Ubiquitin Assembly Complex Modulates Latent Membrane Protein 1 Activation of NF-κB and Interferon Regulatory Factor 7.

Wang L, Wang Y, Zhao J, Ren J, Hall KH, Moorman JP, Yao ZQ, Ning S.

J Virol. 2017 Jan 31;91(4). pii: e01138-16. doi: 10.1128/JVI.01138-16. Print 2017 Feb 15.

10.

IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3.

Song YJ, Izumi KM, Shinners NP, Gewurz BE, Kieff E.

Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18448-53. doi: 10.1073/pnas.0809933105. Epub 2008 Nov 18.

11.

Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination.

Huye LE, Ning S, Kelliher M, Pagano JS.

Mol Cell Biol. 2007 Apr;27(8):2910-8. Epub 2007 Feb 12.

12.

IRF7: activation, regulation, modification and function.

Ning S, Pagano JS, Barber GN.

Genes Immun. 2011 Sep;12(6):399-414. doi: 10.1038/gene.2011.21. Epub 2011 Apr 14. Review.

13.

Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.

Kung CP, Raab-Traub N.

J Virol. 2008 Jun;82(11):5486-93. doi: 10.1128/JVI.00125-08. Epub 2008 Mar 26.

14.

Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.

Edwards RH, Marquitz AR, Raab-Traub N.

MBio. 2015 Apr 14;6(2). pii: e00441-15. doi: 10.1128/mBio.00441-15.

15.

Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.

Martin KA, Lupey LN, Tempera I.

J Virol. 2016 Sep 12;90(19):8520-30. doi: 10.1128/JVI.01180-16. Print 2016 Oct 1.

16.

Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation.

Gewurz BE, Mar JC, Padi M, Zhao B, Shinners NP, Takasaki K, Bedoya E, Zou JY, Cahir-McFarland E, Quackenbush J, Kieff E.

J Virol. 2011 Jul;85(13):6764-73. doi: 10.1128/JVI.00422-11. Epub 2011 May 4.

17.

Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.

Tao YG, Tan YN, Liu YP, Song X, Zeng L, Gu HH, Tang M, Li W, Yi W, Cao Y.

Cell Signal. 2004 Jul;16(7):781-90.

PMID:
15115657
18.

Interferon regulatory factor 7 is involved in the growth of Epstein-Barr virus-transformed human B lymphocytes.

Xu D, Zhang Y, Zhao L, Cao M, Lingel A, Zhang L.

Virus Res. 2015 Jan 2;195:112-8. doi: 10.1016/j.virusres.2014.09.005. Epub 2014 Oct 7.

PMID:
25300801
20.

Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.

Lai KY, Chou YC, Lin JH, Liu Y, Lin KM, Doong SL, Chen MR, Yeh TH, Lin SJ, Tsai CH.

J Virol. 2015 Jun;89(11):5968-80. doi: 10.1128/JVI.00168-15. Epub 2015 Mar 25.

Supplemental Content

Support Center